DOCSLIB.ORG

RELX Group Annual Reports and Financial Statements 2017

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
RELX Group Annual Reports and Financial Statements 2017 Annual Reports and Financial Statements 2017 Annual Reports and Financial Statements Financial Reportsand Annual 2017 RELX Group is a global provider of information and analytics for professional and business customers across industries. We help scientists make new discoveries, lawyers win cases, doctors save lives and insurance companies offer customers lower prices. We save taxpayers and consumers money by preventing fraud and help executives forge commercial relationships with their clients. In short, we enable our customers to make better decisions, get better results and be more productive. RELX PLC is a London listed holding company which owns 52.9% of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1% of RELX Group. Forward-looking statements The Reports and Financial Statements 2017 contains forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those currently being anticipated. The terms “outlook”, “estimate”, “project”, “plan”, “intend”, “expect”, “should be”, “will be”, “believe”, “trends” and similar expressions identify forward-looking statements. Factors which may cause future outcomes to differ from those foreseen in forward-looking statements include, but are not limited to: current and future economic, political and market forces; changes in law and legal interpretations affecting the RELX Group intellectual property rights; regulatory and other changes regarding the collection, transfer or use of third party content and data; demand for the RELX Group products and services; competitive factors in the industries in which the RELX Group operates; compromises of our data security systems and interruptions in our information technology systems; legislative, fiscal, tax and regulatory developments and political risks; exchange rate fluctuations; and other risks referenced from time to time in the filings of RELX PLC and RELX N.V. with the US Securities and Exchange Commission. Overview RELX Group 1 Overview* Overview Contents 2 2017 Financial highlights 3 Chairman’s statement 4 Chief Executive Officer’s report Business review* 8 RELX Group business overview 14 Scientific, Technical & Medical 20 Risk & Business Analytics 28 Legal 34 Exhibitions 41 Corporate Responsibility Business review Financial review* 54 Chief Financial Officer’s report 60 Principal risks Governance 66 Board Directors 68 REL X Group Business Leaders 70 Chairman’s introduction to Corporate Governance 71 Corporate Governance review 81 Report of the Nominations Committee 83 Directors’ Remuneration Report 103 Report of the Audit Committees Financial review Financial statements and other information 106 Independent auditors’ report 117 Consolidated Financial Statements 167 REL X PLC Annual Report and Financial Statements 175 REL X NV Annual Report and Financial Statements 184 Summary financial information in euros 185 Summary financial information in US dollars 186 Reconciliation of adjusted to GA AP measures 187 Shareholder information 191 2018 financial calendar Governance * Comprises the Strategic Report in accordance with The (UK) Companies Act 2006 (Strategic Report and Directors’ Report) Regulations 2013. Financial Financial statements and other information Get more information online A pdf of the full Annual Report and further information about the Group and our businesses can be found online at our website: www.relx.com 2 RELX Group Annual reports and financial statements 2017 2017 Financial highlights § Underlying revenue up 4% § Underlying adjusted operating profit up 6% § Adjusted EPS up 12% to 81.0p (72.2p); up 5% to €0.923 (€0.880); up 7% constant currency § Reported EPS 82.2p (56.3p) for RELX PLC; €0.936 (€0.687) for RELX NV § Full-year dividend up 10% to 39.4p for RELX PLC and up 6% to €0.448 for RELX NV § Strong financial position and cash flow; leverage 2.2x EBITDA pensions and lease adjusted (1.9x unadjusted) RELX Group REVENUE ADJUSTED OPERATING PROFIT £m €m £m €m Underlying growth +4% Underlying growth +6% 8,412 8,385 2,579 2,604 6,895 7,355 2,114 2,284 2016 2017 2016 2017 2016 2017 2016 2017 Parent companies RELX PLC RELX NV Adjusted EPS Dividend Adjusted EPS Dividend pence pence € € Growth +12% Growth +10% Growth +5% Growth +6% 81.0 0.923 72.2 0.880 35.95 39.4 0.423 0.448 2016 2017 2016 2017 2016 2017 2016 2017 REL X Group encompasses REL X PLC, REL X NV, REL X Group plc and its subsidiaries, associates and joint ventures. The corporate structure is set out on page 71. REL X Group uses adjusted and underlying figures as additional performance measures. Adjusted figures primarily exclude the amortisation of acquired intangible assets and other items related to acquisitions and disposals, and the associated deferred tax movements. In 2017, we have excluded the exceptional tax credit arising as a result of the US Tax Cuts and Jobs Act. Reconciliations between the reported and adjusted figures are set out on page 186. Underlying growth rates are calculated at constant currencies, and exclude the results of acquisitions and disposals made in both the year and prior year and of assets held for sale. Underlying revenue growth rates also exclude the effects of exhibition cycling. Constant currency growth rates are based on 2016 full-year average and hedge exchange rates. Overview Chairman’s statement 3 Chairman’s statement Overview as last year, and, on an unadjusted basis was 1.9x, compared with 1.8x last year. Adjusted cash flow conversion was 96%, compared with 95% in 2016, with capital expenditure at 5% of revenues. Share buybacks In 2017, we deployed £700m on share buybacks. In 2018, we intend to deploy a total of £700m. By February, £100m of this year’s total had already been completed, leaving a further £600m to be deployed during the year. Business review The Boards We continue to refresh the Boards. In September 2017, we welcomed Suzanne Wood to the boards as a non-executive director. Suzanne is Group Finance Director at Ashtead Group plc and brings extensive board experience on both sides of the Atlantic. In 2018, Adrian Hennah will become Chairman of the Audit Committees, replacing Ben van der Veer, who will have been on the Boards for nine years in September 2018 and has been Chairman of the Audit Committees since 2010. Sir Anthony Habgood Chairman Parent company structure We are proposing a set of measures that will further simplify our corporate structure into a single parent company. We believe this We achieved good underlying is a natural next step for REL X Group, removing complexity and increasing transparency. The changes will be cost and profit neutral Financial review revenue growth in 2017, and on an ongoing basis and will not impact the economic interests of any shareholder. REL X NV shareholders will receive one new REL X PLC continued to generate underlying share in exchange for each REL X NV share held and will, following the additional listing of REL X PLC shares on Euronext Amsterdam, adjusted operating profit growth have the option of trading new REL X PLC shares on Euronext Amsterdam, priced in euros, and receive dividend payments in ahead of revenue growth. We are euros. REL X PLC will continue to have a premium listing on the London Stock Exchange and we will be applying for an additional proposing a set of measures that listing of REL X PLC on Euronext Amsterdam. REL X NV ADRs will be converted one-for-one to REL X PLC ADRs which will continue to be will further simplify our corporate listed on the New York Stock Exchange. There will be no changes to structure into a single parent the locations, activities or staffing levels of REL X Group or its four business areas. The simplification is subject to the approval of both Governance RELX PLC and RELX NV shareholders. We expect a circular to be company. sent to shareholders in Q2 2018, with implementation in Q3 2018. REL X Group continued to execute well on its strategic priorities Corporate responsibility aimed at achieving more predictable revenues, a higher growth We prioritise excellence in corporate governance across RELX profile and improving returns. As a result, growth of underlying Group. In 2017, we advanced a more structured approach to revenues was again +4%. Underlying adjusted operating profits compliance training for employees in higher-risk roles and grew +6%, as we continued to grow revenues ahead of costs. locations by creating a resource library with presentations on competition law, anti-bribery, anti-harassment, trade sanctions Adjusted earnings per share in constant currencies grew +7%. and fostering a culture of compliance. Over 2,400 colleagues Adjusted EPS expressed in sterling was 81.0p (+12%) or in euros received advanced in-person compliance training. €0.923 (+5%). Reported earnings per share expressed in sterling was 82.2p (56.3p) and expressed in euros was €0.936 (€0.687). Diversity and inclusion remain critical to our business to ensure we The difference in growth rates between the sterling and euro EPS reflect the diversity of our customers and communities. Over 44% reflects the movement in exchange rates. of non-executive directors on the Board are women. In the year, we Financial statements and other information expanded our women in technology mentor pilot to include mentees Dividends in the US and China as well as the UK, and developed a new mentor We are proposing a full year dividend increase of 10% to 39.4p programme for high potential women. for REL X PLC and 6% to €0.448 for REL X NV. The difference in growth rates between the two dividends reflects movement We focus on our unique contributions to society, such as fostering in the sterling/euro exchange rate since the payments a year communities, applying our expertise, and using our convening earlier.
Load more

Recommended publications
  • 2013--Annual-Report-Accounts.Pdf
    Helping people make measurable progress in their lives through learning ANNUAL REPORT AND ACCOUNTS 2013 OUR TRANSFORMATION To find out more about how we are transforming our business go to page 09 EFFICACY To find out more about our focus on efficacy go to page 14 OUR PERFORMANCE For an in-depth analysis of our performance in 2013 go to page 19 Pearson is the world’s leading learning company, with 40,000 employees in more than 80 countries working to help people of all ages to make measurable progress in their lives through learning. We provide learning materials, technologies, assessments and services to teachers and students in order to help people everywhere aim higher and fulfil their true potential. We put the learner at the centre of everything we do. READ OUR REPORT ONLINE Learn more www.pearson.com/ar2013.html/ar2013.html To stay up to date wwithith PPearsonearson throughout the year,r, visit ouourr blog at blog.pearson.comn.com and follow us on Twitteritter – @pearsonplc 01 Heading one OVERVIEW Overview 02 Financial highlights A summary of who we are and what 04 Chairman’s introduction 1 we do, including performance highlights, 06 Our business models our business strategy and key areas of 09 Chief executive’s strategic overview investment and focus. 14 Pearson’s commitment to efficacy OUR PERFORMANCE OUR Our performance 19 Our performance An in-depth analysis of how we 20 Outlook 2014 2 performed in 2013, the outlook 23 Education: North America, International, Professional for 2014 and the principal risks and 32 Financial Times Group uncertainties affecting our businesses.
    [Show full text]
  • Orthopaedic Bioengineering Research Laboratory 2010-2011
    2010-2011 Report including the Orthopaedic Bioengineering Research Laboratory Preface It is my pleasure to present our 2010-2011 report been possible without a number of our donors from the Orthopaedic Research Center and the stepping up to provide supplemental funding. Orthopaedic Bioengineering Research Laboratory I’m particularly grateful to Mr. Jim Kennedy for at Colorado State University. Our principal focus providing supplemental operating funds and continues to be solving the significant problems in continuing the legacy of his mother, Barbara Cox equine musculoskeletal disease as can be seen in this Anthony. I’m also grateful to Abigail Kawananakoa report but we also continue to investigate questions for continued support over and above the Endowed relevant to human joint disease and techniques Chair she donated three years ago; and Herbert Allen and devices for human osteoarthritis and articular for continuing to provide considerable support for cartilage repair when the technique can also benefit investigation of cutting edge therapies. the horse. There have been a number of notable projects in this regard. The studies, led by Dr. Dave We have added an Equine Sports Medicine Frisbie at the ORC in partnership with Dr. Alan Ambulatory clinical arm to the Orthopaedic Research Grodzinsky at MIT on an NIH Program Grant in Center and also initiated two residencies in Sports cartilage repair, have been completed and results Medicine and Rehabilitation. This follows on from are still be analyzed. We have three other ongoing the accreditation of a new specialty college, the NIH grants in partnership with collaborators. One is American College of Veterinary Sports Medicine and with Dr.
    [Show full text]
  • Rb-Annual-Report-2012.Pdf
    Reckitt Benckiser Group plc Reckitt Benckiser Group Healthier Happier Annual Report and Financial Statements 2012 Stronger Reckitt Benckiser Group plc Annual Report and Financial Statements 2012 Contents 1 Chairman’s Statement 2 Chief Executive’s Statement 10 Business Review 2012 18 Board of Directors and Executive Committee 19 Report of the Directors 22 Chairman’s Statement on Corporate Governance 24 Corporate Governance Report 30 Statement of Directors’ Responsibilities 31 Directors’ Remuneration Report 38 Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 39 Group income statement 39 Group statement of comprehensive income 40 Group balance sheet 41 Group statement of changes in equity 42 Group cash flow statement 43 Notes to the financial statements 75 Five-year summary 76 Parent Company – Independent Auditors’ Report to the members of Reckitt Benckiser Group plc 77 Parent Company balance sheet 78 Notes to the Parent Company financial statements 84 Shareholder information Chairman’s Statement largest consumer health care category in The Board conducted its regular reviews the world with the acquisition of Schiff of the Company’s brands, geographic area Nutrition International, Inc. (Schiff) and and functional performance together with its leading US brands in the vitamins, detailed reviews of its human resources. minerals and supplements market. There The Board also completed its annual were also a few disposals of non core assessment of corporate governance assets. Net debt at the end of 2012, after including Board performance, corporate paying for dividends, net acquisitions and responsibility, and reputational and organisation restructuring, stood at business risk. £2,426m (2011: £1,795m). AGM Resolutions Your Board proposes an increase in the final The resolutions, which will be voted dividend of +11%, taking it to 78p per upon at our AGM of 2 May 2013 are share, and bringing the total dividend for fully explained in the Notice of Meeting.
    [Show full text]
  • Portrayals of Religious Studies in Popular Culture Brian Collins Ohio University
    John Carroll University Carroll Collected 2018 Faculty Bibliography Faculty Bibliographies Community Homepage 6-2018 From Middlemarch to The aD Vinci Code: Portrayals of Religious Studies in Popular Culture Brian Collins Ohio University Kristen Tobey John Carroll University, [email protected] Follow this and additional works at: https://collected.jcu.edu/fac_bib_2018 Part of the Religion Commons, and the Television Commons Recommended Citation Collins, Brian and Tobey, Kristen, "From Middlemarch to The aD Vinci Code: Portrayals of Religious Studies in Popular Culture" (2018). 2018 Faculty Bibliography. 55. https://collected.jcu.edu/fac_bib_2018/55 This Article is brought to you for free and open access by the Faculty Bibliographies Community Homepage at Carroll Collected. It has been accepted for inclusion in 2018 Faculty Bibliography by an authorized administrator of Carroll Collected. For more information, please contact [email protected]. From Middlemarch to The Da Vinci Code: Portrayals of Religious Studies in Popular Culture TEMPLE MIDDLEMARCH Directed by Michael Barrett Television serial Screen Media, 2017. 78 minutes Directed by Anthony Page BBC, 1994 DEXTER. SEASON SIX Created by James Manos Jr. MIDDLEMARCH: THE SERIES Showtime, 2011 Directed by Rebecca Shoptaw DEATH DU JOUR YouTube, 2017 By Kathy Reichs New York: Pocket Books, 1999 ANGELS & DEMONS Pp. 480. $17.19 By Dan Brown New York: Washington Square Press, 2006 [2000] THE BLACK TAPES Pp. 496. $17.00 Podcast. Created by Paul Bae and Terry Miles 2015–2017 THE DA VINCI CODE By Dan Brown. THE REAPING New York: Anchor Books, 2009 [2003] Directed by Stephen Hopkins Pp. 597. $9.99 Warner Brothers, 2007. 99 minutes THE LOST SYMBOL SINISTER By Dan Brown Directed by Scott Derickson New York: Anchor Books, 2012 [2009] Blumhouse Productions, 2012.
    [Show full text]
  • Mosby's Comprehensive Review of Radiography
    PERPUSTAKAAN PRIBADI AN-NUR YOU’VE JUST PURCHASED MORE THAN A TEXTBOOK!* Evolve Student Resources for Callaway: Mosby’s Comprehensive Review of Radiography: The Complete Study Guide and Career Planner, Seventh Edition, include the following: • Radiography Practice Exams • Flashcards • Sample Resumes and Cover Letters Activate the complete learning experience that comes with each NEW textbook purchase by registering with your scratch-off access code at http://evolve.elsevier.com/Callaway/radiography/ If you purchased a used book and the scratch-off code at right has already been revealed, the code may have been used and cannot be re-used for registration. To purchase a new code to access these valuable study resources, simply follow the link above. Place Peel Off Sticker Here REGISTER TODAY! You can now purchase Elsevier products on Evolve! Go to evolve.elsevier.com/html/shop-promo.html to search and browse for products. * Evolve Student Resources are provided free with each NEW book purchase only. Mosby’s Comprehensive Review of Radiography The Complete Study Guide and Career Planner Seventh Edition This page intentionally left blank Mosby’s Comprehensive Review of Radiography The Complete Study Guide and Career Planner Seventh Edition William J. Callaway, MA, RT(R) Radiography Educator, Author, Speaker Springfield, Illinois 3251 Riverport Lane St. Louis, Missouri 63043 MOSBY’S COMPREHENSIVE REVIEW OF RADIOGRAPHY: THE COMPLETE STUDY GUIDE AND CAREER PLANNER, SEVENTH EDITION ISBN: 978-0-323-35423-3 Copyright © 2017 Elsevier Inc. All Rights Reserved. Previous editions copyrighted 2013, 2008, 2006, 2002, 2000, 1998, 1995. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording, or any information storage and retrieval system, without permission in writing from the publisher.
    [Show full text]
  • Altmetric.Com and Plumx
    This is a preprint of an article published in Scientometrics. The final authenticated version is available online at: https://doi.org/10.1007/s11192-021-03941-y A large-scale comparison of coverage and mentions captured by the two altmetric aggregators- Altmetric.com and PlumX Mousumi Karmakara, Sumit Kumar Banshalb, Vivek Kumar Singha,1 1Department of Computer Science, Banaras Hindu University, Varanasi-221005, India 2Department of Computer Science, South Asian University, New Delhi-110021, India. Abstract: The increased social media attention to scholarly articles has resulted in creation of platforms & services to track the social media transactions around them. Altmetric.com and PlumX are two such popular altmetric aggregators. Scholarly articles get mentions in different social platforms (such as Twitter, Blog, Facebook) and academic social networks (such as Mendeley, Academia and ResearchGate). The aggregators track activity and events in social media and academic social networks and provide the coverage and transaction data to researchers for various purposes. Some previous studies have compared different altmetric aggregators and found differences in the coverage and mentions captured by them. This paper attempts to revisit the question by doing a large-scale analysis of altmetric mentions captured by the two aggregators, for a set 1,785,149 publication records from Web of Science. Results obtained show that PlumX tracks more altmetric sources and captures altmetric events for a larger number of articles as compared to Altmetric.com. However, the coverage and average mentions of the two aggregators, for the same set of articles, vary across different platforms, with Altmetric.com recording higher mentions in Twitter and Blog, and PlumX recording higher mentions in Facebook and Mendeley.
    [Show full text]
  • 2017 Elsevier Foundation Annual Report
    2017 Elsevier Foundation Report Médecins Sans Frontiers doctors conduct a Phase III rotavirus vaccine trial at Epicentre’s Niger Research Center at the Maradi Hospital, which receives an annual capacity building grant of $100,000 from the Elsevier Foundation. © KRISHAN Cheyenne/MSF White City students at a recent Imperial College London workshop with the student drone society. The Elsevier Foundation supported Maker’s Challenge space will launch in September, hosting future White City students as they navigate 3D printers, tackle robotics and many other tech challenges. © Imperial College London 2017 OWSD-Elsevier Foundation woman scientist award winner Felycia Edi Soetaredjo, PhD, Lecturer at Widya Mandala Surabaya Catholic University in Surabaya, Indonesia, was recognized for her work utilizing waste and cheap materials for environmental remediation of renewable energy. © Widya Mandala Surabaya Catholic University The Elsevier Foundation 2017 Board Report 2 Contents Foreword: Youngsuk “YS” Chi, President of the Elsevier Foundation I. The Elsevier Foundation 1. Who we are 2. Our Board 3. Our Programs 4. Our Future II. Our Programs 1. Health & Innovation 2. Research in Developing Countries 3. Diversity in STM 4. Technology for Development IV. Matching Gift V. Media Outreach VI. Financial Overview VII. Appendix The Elsevier Foundation 2017 Board Report 3 The Elsevier Foundation 2017 Board Report 4 Foreword On the occasion of the September 2017 Elsevier Foundation Board Meeting It has been an incredible privilege to steer collaboration in Sustainability. The TWAS the Elsevier Foundation’s development Elsevier Foundation Program provides over the last decade. I continue to be travel grants for PhD’s and postdoc inspired by the dedication and resolve of scientists studying in sustainability fields this group as we strive to tackle important and hosts case study competitions to global challenges.
    [Show full text]
  • RELX Group Teach-In
    RELX Group Teach-In Thursday, 9th November 2017 RELX Group Teach-In Thursday, 9th November 2017 Welcome Colin Tennant Head of Investor Relations, RELX Group Opening remarks My name is Colin Tennant. I am the Head of Investor Relations at RELX Group. I have three things to do today. First is to welcome everybody. So, welcome, everybody. Second is just a little bit of housekeeping. If the fire alarm does go off during this presentation, you'll be leaving the way you came in. There will be people with fluorescent jackets to help you find the exit. Hopefully, that won't happen. And the final thing I need to do is to introduce the host for today's presentation, Chet Burchett, the Chief Executive of Reed Exhibitions, who is going to lead you through all we are going to cover for today. So, Chet over to you. Overview of Reed Exhibitions Chet Burchett Chief Executive Officer, Reed Exhibitions My Background Thank you, Colin. Good afternoon. As Colin notes, I am, indeed, Chet Burchett. I have been Chief Executive for Reed Exhibitions since 2015. I have been with the company for almost 14 years. I joined in February 2004 as President of North America. I came over from Burson-Marsteller, one of the WPP's global public relations agencies, where I had been serving as Chief Executive for their US business. Then, my role expanded for Reed to President of the Americas when I took on responsibility for our South American business which, at the time, was a small operation in Argentina and a few shows in Brazil.
    [Show full text]
  • Agricultural Engineering Journals in AGRICOLA
    Agricultural Engineering Journals in AGRICOLA https://web.archive.org/web/20030428232053/http://www.usain.org:80... Agricultural and Biosystems Engineering Journal List Valerie Perry, Public Services Librarian, Agricultural Information Center, University of Kentucky, Lexington, KY 40546-0091 Allison Level, Assistant Professor, Morgan Library, Colorado State University, Fort Collins, CO 80523-1019 list from chapter "Agricultural and Biosystems Engineering" by Mary Anderson Ochs and Mary E. Patterson in Using the Agricultural, Environmental and Food Literature ** indicates titles not included in AGRICOLA listing. 4/05/02 ISI AGRICOLA Journal Titles ISSN Publication Information Impact Indexing Factor **Acta biotechnologica. 0138-4988 1981- Berlin: Akademie-Verlag. 0.351 1981- v. 12- Tokyo: Farm Machinery **Agricultural mechanization in Asia, 0084-5841 Industrial Research Corp. Continues N/A Africa and Latin America. Agricultural Mechanization in Southeast Asia. Cover-to-cover 1976- Barking, U.K.: Elsevier Applied Agricultural systems. 0308-521X 0.815 and contains Science. abstracts. Agricultural water management. 0378-3774 1976- Amsterdam: Elsevier. 0.526 Cover-to-cover. Cover-to-cover Agriculture, ecosystems & environment. 0167-8809 1983- Amsterdam; New York: Elsevier. 1.297 and contains abstracts. Selectively and American Society for Microbiology. 1976- v. 31- Washington: American Society 0099-2240 3.688 contains Applied and environmental microbiology. for Microbiology. abstracts. Cover-to-cover 1985- St. Joseph, MI : American Society of Applied engineering in agriculture. 0883-8542 0.249 and contains Agricultural Engineers. abstracts. 1984- v. 19- Berlin: Springer International. Selectively and Applied microbiology and biotechnology. 0175-7598 Continues European Journal of Applied 1.754 contains Microbiology and Biotechnology. abstracts. 1974- London: Intermediate Technology **Appropriate technology.
    [Show full text]
  • RELX Group Annual Reports and Financial Statements 2015
    Annual Reports and Financial Statements 2015 Annual Reports and Financial Statements 2015 RELX Group is a world-leading provider of information and analytics for professional and business customers across industries. We help scientists make new discoveries, lawyers win cases, doctors save lives and insurance companies offer customers lower prices. We save taxpayers and consumers money by preventing fraud and help executives forge commercial relationships with their clients. In short, we enable our customers to make better decisions, get better results and be more productive. RELX PLC is a London listed holding company which owns 52.9 percent of RELX Group. RELX NV is an Amsterdam listed holding company which owns 47.1 percent of RELX Group. Forward-looking statements The Reports and Financial Statements 2015 contain forward-looking statements within the meaning of Section 27A of the US Securities Act of 1933, as amended, and Section 21E of the US Securities Exchange Act of 1934, as amended. These statements are subject to a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those currently being anticipated. The terms “estimate”, “project”, “plan”, “intend”, “expect”, “should be”, “will be”, “believe”, “trends” and similar expressions identify forward-looking statements. Factors which may cause future outcomes to differ from those foreseen in forward-looking statements include, but are not limited to competitive factors in the industries in which the Group operates; demand for the Group’s products and services; exchange rate fluctuations; general economic and business conditions; legislative, fiscal, tax and regulatory developments and political risks; the availability of third-party content and data; breaches of our data security systems and interruptions in our information technology systems; changes in law and legal interpretations affecting the Group’s intellectual property rights and other risks referenced from time to time in the filings of the Group with the US Securities and Exchange Commission.
    [Show full text]
  • Military Physician
    MILITARY PHYSICIAN Military Physician Program Council and Peer Review Board Members Quarterly Official Organ of the Section of Military Physicians at the Polish Chairman Medical Society Grzegorz Gielerak – Head of the Military Institute of Medicine Oficjalny Organ Sekcji Lekarzy Wojskowych Polskiego Towarzystwa Lekarskiego Members Scientific Journal of the Military Institute of Medicine Massimo Barozzi (Italy) Pismo Naukowe Wojskowego Instytutu Medycznego Anna Hauska-Jung (Poland) Published since 3 January 1920 Wiesław W. Jędrzejczak (Poland) Number of points assigned by the Polish Ministry of Science and Higher Dariusz Jurkiewicz (Poland) Paweł Kaliński (USA) Education (MNiSW) – 4 Frederick C. Lough (USA) Marc Morillon (Belgium) Arnon Nagler (Israel) Stanisław Niemczyk (Poland) Editorial Board Krzysztof Paśnik (Poland) Francis J. Ring (UK) Editor-in-Chief Daniel Schneditza (Austria) Jerzy Kruszewski MD, PhD Zofia Wańkowicz (Poland) Deputy Editors-in-Chief Krzysztof Korzeniewski Marek Maruszyński Piotr Rapiejko Secretary Ewa Jędrzejczak Editorial Office Military Institute of Medicine 128 Szaserów St., 04-141 Warsaw 44, Poland telephone/fax: +48 261 817 380 e-mail: [email protected] www.lekarzwojskowy.pl © Copyright by Military Institute of Medicine Practical Medicine Publishing House / Medycyna Praktyczna 2 Rejtana St., 30-510 Kraków, Poland Telephone: +48 12 29 34 020, fax: +48 12 29 34 030 e-mail: [email protected] Managing Editor Lidia Miczyńska Proofreading Dariusz Rywczak, Iwona Żurek Cover Design Krzysztof Gontarski Typesetting Łukasz Łukasiewicz DTP Katarzyna Opiela Advertising For many years, “Military Physician” has been indexed in the Piotr Lorens MD Polish Medical Bibliography (Polska Bibliografia Lekarska), the tel. +48 663 430 191; e-mail: [email protected] oldest Polish bibliographic database.
    [Show full text]
  • Chronicle, Literature, and Film from the Post-Gatekeeper Period
    University of Kentucky UKnowledge Theses and Dissertations--Hispanic Studies Hispanic Studies 2013 Telling the Story of Mexican Migration: Chronicle, Literature, and Film from the Post-Gatekeeper Period Ruth Brown University of Kentucky, [email protected] Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Brown, Ruth, "Telling the Story of Mexican Migration: Chronicle, Literature, and Film from the Post- Gatekeeper Period" (2013). Theses and Dissertations--Hispanic Studies. 11. https://uknowledge.uky.edu/hisp_etds/11 This Doctoral Dissertation is brought to you for free and open access by the Hispanic Studies at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Hispanic Studies by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained and attached hereto needed written permission statements(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine). I hereby grant to The University of Kentucky and its agents the non-exclusive license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known. I agree that the document mentioned above may be made available immediately for worldwide access unless a preapproved embargo applies.
    [Show full text]